News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
686,260 Results
Type
Article (39080)
Company Profile (279)
Press Release (646901)
Section
Business (203876)
Career Advice (1992)
Deals (35364)
Drug Delivery (86)
Drug Development (80814)
Employer Resources (168)
FDA (16092)
Job Trends (14805)
News (344573)
Policy (32440)
Tag
Academia (2530)
Alliances (49111)
Alzheimer's disease (1239)
Approvals (16025)
Artificial intelligence (141)
Bankruptcy (352)
Best Places to Work (11548)
Biotechnology (200)
Breast cancer (135)
Cancer (1145)
Cardiovascular disease (103)
Career advice (1660)
Cell therapy (240)
Clinical research (64350)
Collaboration (407)
Compensation (211)
COVID-19 (2533)
C-suite (101)
Data (1175)
Diabetes (157)
Diagnostics (6156)
Earnings (84844)
Employer resources (146)
Events (109709)
Executive appointments (326)
FDA (16660)
Funding (372)
Gene therapy (182)
GLP-1 (581)
Government (4327)
Healthcare (18681)
Infectious disease (2619)
Inflammatory bowel disease (108)
Interviews (308)
IPO (16311)
Job creations (3624)
Job search strategy (1417)
Layoffs (414)
Legal (7854)
Lung cancer (174)
Manufacturing (179)
Medical device (13187)
Medtech (13192)
Mergers & acquisitions (19153)
Metabolic disorders (410)
Neuroscience (1527)
NextGen Class of 2024 (6499)
Non-profit (4464)
Northern California (1539)
Obesity (234)
Opinion (179)
Patents (108)
People (56313)
Phase I (19992)
Phase II (28340)
Phase III (21133)
Pipeline (475)
Postmarket research (2555)
Preclinical (8504)
Radiopharmaceuticals (236)
Rare diseases (228)
Real estate (5890)
Regulatory (21561)
Research institute (2309)
Resumes & cover letters (349)
Southern California (1335)
Startups (3562)
United States (13939)
Vaccines (553)
Weight loss (169)
Date
Today (108)
Last 7 days (381)
Last 30 days (3263)
Last 365 days (35503)
2024 (33365)
2023 (40074)
2022 (51173)
2021 (55712)
2020 (54087)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31482)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (193)
Asia (37170)
Australia (6065)
California (3449)
Canada (1336)
China (268)
Colorado (151)
Connecticut (159)
Europe (79583)
Florida (481)
Georgia (122)
Illinois (351)
Indiana (204)
Kansas (96)
Maryland (595)
Massachusetts (2711)
Michigan (160)
Minnesota (277)
New Jersey (992)
New York (996)
North Carolina (714)
Northern California (1539)
Ohio (142)
Pennsylvania (866)
South America (1091)
Southern California (1335)
Texas (495)
Utah (92)
Washington State (371)
686,260 Results for "shouti inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
ShouTi’s Rationally Designed Small Molecules are Challenging Biologics and Peptides
ShouTi believes many targets addressed by biologic and peptide therapeutics can be reached by innovative, rationally-designed, best-in-class small molecules that don’t need refrigeration or injection.
May 17, 2022
·
4 min read
·
Gail Dutton
Business
ShouTi Appoints Sharon Tetlow to Board of Directors
ShouTi Inc., a clinical-stage global biopharmaceutical company developing novel oral therapeutics to treat a wide range of chronic diseases, announced the appointment of Sharon Tetlow to the company’s board of directors.
March 29, 2022
·
2 min read
Drug Development
Structure Therapeutics Extends Financing, Advances Diabetes and Obesity Clinical Program and Changes Name from ShouTi
Structure Therapeutics Inc. (Structure Therapeutics), formerly known as ShouTi Inc., today announced it closed an oversubscribed $33 million financing round, extending its $100 million Series B financing, which was announced in October 2021.
August 1, 2022
·
4 min read
Business
ShouTi Introduces Basecamp Bio as a Wholly Owned Subsidiary to Expand Pipeline and Partnerships
ShouTi Introduces Basecamp Bio as a Wholly Owned Subsidiary to Expand Pipeline and Partnerships.
February 17, 2022
·
3 min read
Business
ShouTi Strengthens Board With Appointment of Daniel G. Welch as Chairman
ShouTi Inc., a clinical-stage biopharmaceutical company replacing biologics with world-class small molecule medicines using advanced computational and structure-based technology, announced that Daniel Welch has been named Chairman of the company’s board of directors.
January 20, 2022
·
3 min read
Business
ShouTi Appoints Ding Ding, Ph.D., as Chief Financial Officer
ShouTi Inc., a clinical-stage biopharmaceutical company creating world-class small molecule medicines using advanced computational and structure-based technology, announced the appointment of Ding Ding, Ph.D., as Chief Financial Officer.
December 21, 2021
·
2 min read
Biotech Bay
ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform
ShouTi Inc., today announced the close of a $100 million Series B financing led by BVF Partners L.P. (BVF).
October 20, 2021
·
4 min read
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
Press Releases
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
November 26, 2024
·
9 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
1 of 68,626
Next
